Cargando…

OR14-3 Disrupted circadian rhythm in catecholamines in youth-onset Type 2 Diabetes

OBJECTIVES: In healthy, normal - weight adults there is a circadian rhythm in blood pressure (BP) and plasma catecholamines (epinephrine and norepinephrine): BP and the levels of norepinephrine and epinephrine decline during sleep, followed by a rapid increase during the early morning hours. Studies...

Descripción completa

Detalles Bibliográficos
Autores principales: Armstrong, Sarah, Bain, James R, Crawford, Matthew, Freemark, Michael, Grant, Russell P, Gumus Balikcioglu, Pinar, Hsia, Daniel S, Jain, Nina, Muehlbauer, Michael, Ramaker, Megan, Blew, Kathryn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625748/
http://dx.doi.org/10.1210/jendso/bvac150.1273
_version_ 1784822578511085568
author Armstrong, Sarah
Bain, James R
Crawford, Matthew
Freemark, Michael
Grant, Russell P
Gumus Balikcioglu, Pinar
Hsia, Daniel S
Jain, Nina
Muehlbauer, Michael
Ramaker, Megan
Blew, Kathryn
author_facet Armstrong, Sarah
Bain, James R
Crawford, Matthew
Freemark, Michael
Grant, Russell P
Gumus Balikcioglu, Pinar
Hsia, Daniel S
Jain, Nina
Muehlbauer, Michael
Ramaker, Megan
Blew, Kathryn
author_sort Armstrong, Sarah
collection PubMed
description OBJECTIVES: In healthy, normal - weight adults there is a circadian rhythm in blood pressure (BP) and plasma catecholamines (epinephrine and norepinephrine): BP and the levels of norepinephrine and epinephrine decline during sleep, followed by a rapid increase during the early morning hours. Studies in adults with Type 2 diabetes (T2D) show blunted reductions in BP and plasma catecholamine levels during sleep that are associated with increased risks for heart failure, stroke, myocardial infarction, and sudden death. In this study, we explored if the circadian rhythm in catecholamines is disrupted in youth-onset T2D. We hypothesized that increased sympatho-adrenal activity during sleep differentiates youth with T2D from non-diabetic overweight/obese and lean youth of comparable age, pubertal status, and ethnicity. To that end, we measured urine catecholamines in fasting – morning-spot urines and 24-hour urine samples. METHODS: 56 non-diabetic adolescents with overweight/obesity ("obese"), 42 adolescents with T2D ("T2D"), and 43 normal-weight controls ("lean"); aged 12-21 years, were studied. None was diagnosed with hypertension, and none was on antihypertensive treatment. Weight, height, BMI, BMI%, and BP were extracted from medical charts. Body fat percent (BF%) was measured by TANITA. Stress levels were assessed using PHQ-2 and PHQ-9 questionnaires. Fractionated free urine catecholamines (epinephrine, norepinephrine, and dopamine) were analyzed by liquid chromatography/tandem mass spectrometry (LC/MS-MS) in both spot and 24-hour urines, normalized to urinary creatinine. The ratio of fasting morning urine catecholamines to 24-hour urine catecholamines was calculated to assess circadian variation in catecholamines. Group differences were assessed by Kruskal-Wallis or ANOVA. RESULTS: Groups were comparable for age (obese 14.8 +/- 1.9; T2D 15.7 +/- 2.1 and lean 14.9 +/- 1.9-yr), pubertal status, and ethnicity. Obese youth with and without T2D were predominantly female (T2D, 28 F, 14 M; obese 33 F, 23 M; lean, 17 F, 26 M); those with T2D had highest BF% (obese 37.3 +/- 9.5; T2D 42.9 +/- 9.9; lean 20.1 +/- 6.3%; p=2.58e-22) and systolic blood pressure (obese 115.36 +/- 11.54; T2D 127.83 +/- 12.08 and lean 111.65 +/- 9.13 mmHg; p=5.49e-10). Fractionated free urine catecholamines (epinephrine, norepinephrine and dopamine) were comparable across groups in 24-hour urines. However, fasting morning epinephrine levels and the ratio of fasting morning/24-hour epinephrine were higher in T2D (p=0.0035, and p=0.035, respectively) than in either lean or nondiabetic youth with obesity. There were no differences in morning urine catecholamines between lean controls and non-diabetic youth with obesity. CONCLUSIONS: Our results suggest a disrupted circadian rhythm in catecholamines in youth-onset T2D, with a blunted overnight fall in epinephrine levels. Higher levels of epinephrine levels at night in youth with T2D might be associated with, or predispose to, hypertension and long-term cardiovascular complications. Presentation: Sunday, June 12, 2022 11:30 a.m. - 11:45 a.m.
format Online
Article
Text
id pubmed-9625748
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-96257482022-11-14 OR14-3 Disrupted circadian rhythm in catecholamines in youth-onset Type 2 Diabetes Armstrong, Sarah Bain, James R Crawford, Matthew Freemark, Michael Grant, Russell P Gumus Balikcioglu, Pinar Hsia, Daniel S Jain, Nina Muehlbauer, Michael Ramaker, Megan Blew, Kathryn J Endocr Soc Pediatric Endocrinology OBJECTIVES: In healthy, normal - weight adults there is a circadian rhythm in blood pressure (BP) and plasma catecholamines (epinephrine and norepinephrine): BP and the levels of norepinephrine and epinephrine decline during sleep, followed by a rapid increase during the early morning hours. Studies in adults with Type 2 diabetes (T2D) show blunted reductions in BP and plasma catecholamine levels during sleep that are associated with increased risks for heart failure, stroke, myocardial infarction, and sudden death. In this study, we explored if the circadian rhythm in catecholamines is disrupted in youth-onset T2D. We hypothesized that increased sympatho-adrenal activity during sleep differentiates youth with T2D from non-diabetic overweight/obese and lean youth of comparable age, pubertal status, and ethnicity. To that end, we measured urine catecholamines in fasting – morning-spot urines and 24-hour urine samples. METHODS: 56 non-diabetic adolescents with overweight/obesity ("obese"), 42 adolescents with T2D ("T2D"), and 43 normal-weight controls ("lean"); aged 12-21 years, were studied. None was diagnosed with hypertension, and none was on antihypertensive treatment. Weight, height, BMI, BMI%, and BP were extracted from medical charts. Body fat percent (BF%) was measured by TANITA. Stress levels were assessed using PHQ-2 and PHQ-9 questionnaires. Fractionated free urine catecholamines (epinephrine, norepinephrine, and dopamine) were analyzed by liquid chromatography/tandem mass spectrometry (LC/MS-MS) in both spot and 24-hour urines, normalized to urinary creatinine. The ratio of fasting morning urine catecholamines to 24-hour urine catecholamines was calculated to assess circadian variation in catecholamines. Group differences were assessed by Kruskal-Wallis or ANOVA. RESULTS: Groups were comparable for age (obese 14.8 +/- 1.9; T2D 15.7 +/- 2.1 and lean 14.9 +/- 1.9-yr), pubertal status, and ethnicity. Obese youth with and without T2D were predominantly female (T2D, 28 F, 14 M; obese 33 F, 23 M; lean, 17 F, 26 M); those with T2D had highest BF% (obese 37.3 +/- 9.5; T2D 42.9 +/- 9.9; lean 20.1 +/- 6.3%; p=2.58e-22) and systolic blood pressure (obese 115.36 +/- 11.54; T2D 127.83 +/- 12.08 and lean 111.65 +/- 9.13 mmHg; p=5.49e-10). Fractionated free urine catecholamines (epinephrine, norepinephrine and dopamine) were comparable across groups in 24-hour urines. However, fasting morning epinephrine levels and the ratio of fasting morning/24-hour epinephrine were higher in T2D (p=0.0035, and p=0.035, respectively) than in either lean or nondiabetic youth with obesity. There were no differences in morning urine catecholamines between lean controls and non-diabetic youth with obesity. CONCLUSIONS: Our results suggest a disrupted circadian rhythm in catecholamines in youth-onset T2D, with a blunted overnight fall in epinephrine levels. Higher levels of epinephrine levels at night in youth with T2D might be associated with, or predispose to, hypertension and long-term cardiovascular complications. Presentation: Sunday, June 12, 2022 11:30 a.m. - 11:45 a.m. Oxford University Press 2022-11-01 /pmc/articles/PMC9625748/ http://dx.doi.org/10.1210/jendso/bvac150.1273 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Pediatric Endocrinology
Armstrong, Sarah
Bain, James R
Crawford, Matthew
Freemark, Michael
Grant, Russell P
Gumus Balikcioglu, Pinar
Hsia, Daniel S
Jain, Nina
Muehlbauer, Michael
Ramaker, Megan
Blew, Kathryn
OR14-3 Disrupted circadian rhythm in catecholamines in youth-onset Type 2 Diabetes
title OR14-3 Disrupted circadian rhythm in catecholamines in youth-onset Type 2 Diabetes
title_full OR14-3 Disrupted circadian rhythm in catecholamines in youth-onset Type 2 Diabetes
title_fullStr OR14-3 Disrupted circadian rhythm in catecholamines in youth-onset Type 2 Diabetes
title_full_unstemmed OR14-3 Disrupted circadian rhythm in catecholamines in youth-onset Type 2 Diabetes
title_short OR14-3 Disrupted circadian rhythm in catecholamines in youth-onset Type 2 Diabetes
title_sort or14-3 disrupted circadian rhythm in catecholamines in youth-onset type 2 diabetes
topic Pediatric Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625748/
http://dx.doi.org/10.1210/jendso/bvac150.1273
work_keys_str_mv AT armstrongsarah or143disruptedcircadianrhythmincatecholaminesinyouthonsettype2diabetes
AT bainjamesr or143disruptedcircadianrhythmincatecholaminesinyouthonsettype2diabetes
AT crawfordmatthew or143disruptedcircadianrhythmincatecholaminesinyouthonsettype2diabetes
AT freemarkmichael or143disruptedcircadianrhythmincatecholaminesinyouthonsettype2diabetes
AT grantrussellp or143disruptedcircadianrhythmincatecholaminesinyouthonsettype2diabetes
AT gumusbalikcioglupinar or143disruptedcircadianrhythmincatecholaminesinyouthonsettype2diabetes
AT hsiadaniels or143disruptedcircadianrhythmincatecholaminesinyouthonsettype2diabetes
AT jainnina or143disruptedcircadianrhythmincatecholaminesinyouthonsettype2diabetes
AT muehlbauermichael or143disruptedcircadianrhythmincatecholaminesinyouthonsettype2diabetes
AT ramakermegan or143disruptedcircadianrhythmincatecholaminesinyouthonsettype2diabetes
AT blewkathryn or143disruptedcircadianrhythmincatecholaminesinyouthonsettype2diabetes